Perceptive Advisors LLC

SEC CIK: 0001224962
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

XENE holding history

Xenon Pharmaceuticals Inc. in every 13F filed by Perceptive Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XENE overview All 13F holders of XENE Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 20; Since Q1 2021

Holdings of XENE by Perceptive Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−200,791−100.0%	Sold out	Holders
Q4 2025	200,791	$9.00M	0.2%	00.0%	Unchanged	Holders
Q3 2025	200,791	$8.06M	0.2%	00.0%	Unchanged	Holders
Q2 2025	200,791	$6.28M	0.2%	−124,533−38.3%	Reduced	Holders
Q1 2025	325,324	$10.9M	0.4%	00.0%	Unchanged	Holders
Q4 2024	325,324	$12.8M	0.4%	−199,606−38.0%	Reduced	Holders
Q3 2024	524,930	$20.7M	0.4%	−58,326−10.0%	Reduced	Holders
Q2 2024	583,256	$22.7M	0.5%	−308,952−34.6%	Reduced	Holders
Q1 2024	892,208	$38.4M	0.7%	−208,540−18.9%	Reduced	Holders
Q4 2023	1,100,748	$50.7M	1.1%	+483,248+78.3%	Added	Holders
Q3 2023	617,500	$21.1M	0.7%	−605,877−49.5%	Reduced	Holders
Q2 2023	1,223,377	$47.1M	1.4%	−608,797−33.2%	Reduced	Holders
Q1 2023	1,832,174	$65.6M	1.9%	−89,099−4.6%	Reduced	Holders
Q4 2022	1,921,273	$75.8M	2.2%	−201,262−9.5%	Reduced	Holders
Q3 2022	2,122,535	$76.6M	2.2%	00.0%	Unchanged	Holders
Q2 2022	2,122,535	$64.6M	2.0%	−288,912−12.0%	Reduced	Holders
Q1 2022	2,411,447	$73.7M	1.5%	00.0%	Unchanged	Holders
Q4 2021	2,411,447	$75.3M	1.2%	+389,396+19.3%	Added	Holders
Q3 2021	2,022,051	$30.9M	0.5%	+343,078+20.4%	Added	Holders
Q2 2021	1,678,973	$31.3M	0.4%	+1,163,931+226.0%	Added	Holders
Q1 2021	515,042	$9.22M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.